Novo Nordisk’s new insulin affordability offerings now available in the US
• My$99Insulin: All patients can purchase up to three vials or two packs of FlexPen®/FlexTouch®/Penfill® pens of any combination of insulins from Novo Nordisk Inc. for $99
• Follow-on brand insulins: Authorized generics of NovoLog® and NovoLog Mix® made by new Novo Nordisk A/S US company, Novo Nordisk Pharma, Inc., available at pharmacies within 1-3 business days at 50 percent off the list price
• Immediate Supply: New, immediate, one-time insulin supply option available for people facing an acute need when more time is needed to identify a long-term sustainable solution
Visit NovoCare.com for more information on new and existing programs for people with and without insurance
PLAINSBORO, N.J., January 2, 2020 /PRNewswire/ – Today, Novo Nordisk launched the My$99Insulin Program, follow-on brands of insulins, and an Immediate Supply option, expanding its insulin affordability offerings to help people with diabetes who need alternative solutions. These options, along with information on the existing patient assistance program, copay cards, and where to find $25/vial human insulin, are now available online at NovoCare.com or by calling 1.844.NOVO4ME (1.844.668.6463).
“We know some people still struggle to afford their insulin and we want to help. We’ve talked to people, including those who have been critical of us, and it’s clear there is no one solution that will work for everyone and people need options,” said Doug Langa, executive vice president, North America Operations and president of Novo Nordisk Inc. “That’s why today, we have made available additional options recognizing the different situations that make insulin unaffordable or inaccessible. With these programs, in conjunction with NNI’s investment in rebates to ensure our medicines are on formularies, we are continuing to take action to help people with diabetes afford their insulin as we work toward much needed longer-term change.”
You may qualify for a clinical study currently enrolling in West Palm Beach.
An investigational topical cream for the treatment of vitiligo is being tested. Candidates for this study will include men & women, 12 years of age or older, who have been diagnosed with vitiligo. Additional eligibility criteria also apply.
Qualified Study Participants may receive:
• Reimbursement up to $650 for travel and study-related expenses
• Study-related care at no cost from local doctors
• Study medication at no cost
For more information, please call: Metabolic Research Institute Inc. at 561-802-3060 or visit: https://www.metabolic-institute.com/vitiligo-study/
ABOUT METABOLIC RESEARCH INSTITUTE, INC. (“MRI”)
Clinical studies are an integral part of clinical research and are at the heart of all advances in modern medicine. Our mission at the Metabolic Research Institute is to provide our patients and sponsors with the highest quality of diabetes clinical research available in today’s medical professional environment. We are committed to delivering efficient and timely research data, while focusing on strict adherence to protocol guidelines.
Metabolic Research Institute, Inc. (“MRI”), is a private Clinical Research Company located at 1515 North Flagler Drive, Suite 440, West Palm Beach Florida 33401. Unless otherwise noted, all study-related appointments for qualified clinical participants in any MRI research trial will take place at this address.
Today, we have better approaches in treating diabetes & other endocrine disorders.
Why? Because people like you took part in a clinical research trial.
Ask if one is right for you.
We enroll adult volunteers in clinical research studies in the following areas:
- Type 1 Diabetes
- Type 2 Diabetes
- Hypertension
- High Cholesterol and/orTriglycerides
- Kidney Disease (Nephropathy)
- Peripheral Neuropathy
- Weight loss
There is no cost to participate in these research studies, and health insurance is not required.
Qualified participants will receive all study related examinations, lab tests and study medications at no cost. You may also be reimbursed for your time and travel.
For more information , talk with your doctor, call (561) 802-3060 or visit: www.metabolic-institute.com
ABOUT METABOLIC RESEARCH INSTITUTE:
Clinical studies are an integral part of clinical research and are at the heart of all advances in modern medicine. Our mission at the Metabolic Research Institute is to provide our patients and sponsors with the highest quality of diabetes clinical research available in today’s medical professional environment. We are committed to delivering efficient and timely research data, while focusing on strict adherence to protocol guidelines.
Metabolic Research Institute, Inc. (“MRI”), is a private Clinical Research Company located at 1515 North Flagler Drive, Suite 440, West Palm Beach Florida 33401. Unless otherwise noted, all study-related appointments for qualified clinical participants in any MRI research trial will take place at this address.
Our recent Eczema Study | Lunch and Learn event was a great success. Dr. Thomas Ross, a local dermatologist with over 20 years of experience, shared with our attendees many new and interesting facts about Eczema (Atopic Dermatitis) including its underlying causes, diagnosis and the treatments currently available to ease the skin conditions related to the disease.
Metabolic Research Institute Inc. (“MRI”) is currently recruiting volunteers for a clinical research study evaluating the safety and effectiveness of an investigational topical cream for use by patients aged 12 – 70 who have been diagnosed with mild to moderate eczema (atopic dermatitis). If you (or someone you know) has been diagnosed with eczema (atopic dermatitis) and is interested in learning more about this study, please call MRI (561) 802-3060 or visit: https://www.metabolic-institute.com/dermatitis/
Recent Comments